TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Takeda Pharma AB
Closing information (x1000 EUR)
Closing information | 2024/03 | 2023/03 | 2022/03 |
Turnover |
197,976
|
182,460
|
170,942 |
Financial expenses |
287
|
1,409
|
428 |
Earnings before taxes |
6,462
|
5,534
|
5,850 |
EBITDA |
6,829
|
6,254
|
6,153 |
Total assets |
77,015
|
68,988
|
69,141 |
Current assets |
76,582
|
68,469
|
68,107 |
Current liabilities |
50,309
|
46,604
|
49,094 |
Equity capital |
26,487
|
22,140
|
19,705 |
- share capital |
174
|
177
|
193 |
Employees (average) |
99
|
101
![]() |
101 |
Financial ratios
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Solvency |
34.4%
|
32.1%
|
28.5% |
Turnover per employee |
2,000
|
1,807
|
1,692 |
Profit as a percentage of turnover |
3.3%
|
3.0%
|
3.4% |
Return on assets (ROA) |
8.8%
|
10.1%
|
9.1% |
Current ratio |
152.2%
|
146.9%
|
138.7% |
Return on equity (ROE) |
24.4%
|
25.0%
|
29.7% |
Change turnover |
19,457
|
25,733
|
-28,587 |
Change turnover % |
11%
|
16%
|
-14% |
Chg. No. of employees |
-2
|
0
|
-11 |
Chg. No. of employees % |
-2%
|
0%
|
-10% |
Total value of public sale
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.